- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05247190
Treating Self-criticism in Adolescents: a Study With Single-case Experimental Design
October 25, 2024 updated by: Maria Zetterqvist, Region Östergötland
In this pilot study, the effect of a group intervention targeting self-criticism in adolescents in a clinical child- and adolescent psychiatric outpatient setting will be examined using a single-case experimental design (AB).
Participants will be randomized to multiple baseline with weekly measures.
Our primary outcomes, measured weekly, are self-criticism, nonsuicidal self-injury and symptoms of depression and anxiety, as well as an individually chosen behavior driven by self-criticism.
Secondary outcomes are self-compassion, psychological flexibility, quality of life and functioning.
In addition to the weekly administered questionnaires, before and after measures, and 3- and 6-month follow-up will be collected.
After the treatment, participants will also be interviewed about their experiences of targeting self-criticism.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Linköping, Sweden, 581 85
- Region Östergötland BUP-kliniken
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patient at the child- and adolescent psychiatric clinic in Linköping, Sweden.
- 15 to 18 years
- an adequate understanding of the Swedish language
- cognitively capable of giving informed consent
- scoring 26 or above on subscale "Inadequate self" and 8.5 or above on subscale "Hated Self" on questionnaire Forms of Self-Criticism and Self-Reassuring Scale (FSCRS)
- the treatment is transdiagnostic so all diagnoses are included (See exclusion criteria for exceptions).
Exclusion Criteria:
- severe anorexia, BMI ≤ 16
- ongoing substance abuse
- diagnosed intellectual disability
- needing interpreter for translation of Swedish language
- participants who cannot give informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treating self-criticism
8-session group intervention targeting self-criticism given 2-hrs/week with booster session after 3-months.
|
A psychological treatment given i a group format targeting self-criticism.
The treatment is based on treatment principles from Cognitive behavior therapy, Self-compassion, Acceptance and Commitment Therapy and also contains psychoeducation.
The group treatment consists of 8 sessions delivered once a week for 2 hrs during 8 weeks in a child- and adolescent psychiatric outpatient setting.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-criticism
Time Frame: Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
|
Forms of Self-Criticism and Self-Reassuring Scale (FSCRS; Gilbert et al., 2004)
|
Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Symptoms of depression
Time Frame: Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
|
Montgomery Åsberg Depression Rating Scale, self-report version (MADRS-S; Montgomery et al., 1979).
|
Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
|
|
Symptoms of anxiety
Time Frame: Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
|
Liebowitz Social Anxiety Scale, self-report (LSAS; Liebowitz, 1987)
|
Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
|
|
Nonsuicidal self-injury
Time Frame: Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
|
Selected items from Self-Injurious Thoughts and Behaviors interview (SITBI; Nock et al., 2007), Deliberate self-harm inventory (DSHI; Gratz et al., 2001) och Clinician Administered Nonsuicidal self-injury Disorder Interview (CANDI; Gratz et al., 2015)
|
Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
|
|
Individually chosen behavior
Time Frame: Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
|
A behavior driven by self-criticism
|
Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
|
|
Self-Compassion
Time Frame: Change from before to after intervention, and at 3- and 6- month follow-up
|
Self-Compassion Scale, short form (SCS; Raes et al., 2011)
|
Change from before to after intervention, and at 3- and 6- month follow-up
|
|
Psychological flexibility
Time Frame: Change from before to after intervention, and at 3- and 6- month follow-up
|
Avoidance and Fusion Questionnaire for Youth (AFQ-Y8; Greco et al., 2008).
|
Change from before to after intervention, and at 3- and 6- month follow-up
|
|
Quality of life and functioning
Time Frame: Change from before to after intervention, and at 3- and 6- month follow-up
|
The Work and Social Adjustment Scale, youth version (WSAS-Y; Mundt et al., 2002).
|
Change from before to after intervention, and at 3- and 6- month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maria Zetterqvist, PhD, Region Östergötland and Linköping university
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 3, 2021
Primary Completion (Actual)
June 27, 2023
Study Completion (Actual)
June 27, 2023
Study Registration Dates
First Submitted
January 27, 2022
First Submitted That Met QC Criteria
February 9, 2022
First Posted (Actual)
February 18, 2022
Study Record Updates
Last Update Posted (Actual)
October 29, 2024
Last Update Submitted That Met QC Criteria
October 25, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-04939
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
Clinical Trials on Treating self-criticism
-
King's College LondonSouth London and Maudsley NHS Foundation TrustCompleted
-
University Medical Center GroningenUniversity of Groningen; PPOCompletedSelf-CriticismNetherlands
-
The University of Hong KongTung Wah Group of HospitalsCompletedParenting | Family | Family Research
-
VIVA PhysiciansPrairie Education and Research CooperativeCompletedPeripheral Vascular Diseases | Chronic Critical Limb IschemiaUnited States
-
Al-Azhar UniversityRecruitingBenign Prostatic HyperplasiaEgypt
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de NiceTerminated
-
University of LeipzigMedical University of Cologne; Deutsche José Carreras Leukämie-Stiftung e.V...Completed
-
University Hospital, Basel, SwitzerlandCompletedDiagnoses Disease | Simulation of Physical Illness | Error DisclosureSwitzerland
-
ArkinFonds NutsOhraCompletedAttention Deficit Hyperactivity Disorder | Substance Use DisordersNetherlands